- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01798472
Hip Fractures Treated With Uncemented Arthroplasties (HUA)
Cemented Versus Uncemented Arthroplasty in Elderly Patients With Displaced Femoral Neck Fractures: a Randomized Controlled Trial
The aim of this study is to compare the functional and radiological outcome after displaced, femoral neck fractures treated with either cemented or uncemented arthroplasties.
The primary hypothesis is that the uncemented arthroplasty shows the same functional outcome at 12 month as the cemented arthroplasty.
Study Overview
Status
Conditions
Detailed Description
Femoral neck fracture is a common cause of suffering and premature mortality among the elderly. Riskfactors for femoral neck fractures are age, gender, osteoporosis and cognitive dysfunction.
Mortality and morbidity varies between undisplaced and displaced femoral neck fractures.
Different treatment options are available: reduction and internal fixation vs joint replacement (arthroplasty). The treatment of undisplaced femoral neck fractures is uncontroversial and consists of internal fixation with screws.
The treatment of displaced, femoral neck fractures with internal fixation shows unacceptable results with complications rates leading to reoperation between 40-60%. Treatment of these fractures with arthroplasties has therefore become the standard treatment in industrial countries.
Fixation of the femoral component with bone-cement is standard procedure in Europe today. To avoid negative cardio-pulmonary events in patients with serious comorbidities and in very old and frail patients uncemented femoral components or internal fixation are used. These uncemented stems are mostly older design with poor track records. The use of modern, well-documented stems used in an osteoarthritis population for fracture patients has still to be tested.
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Contact
- Name: Christian Inngul, MD
- Phone Number: 0046708355969
- Email: christian.inngul@sodersjukhuset.se
Study Locations
-
-
-
Stockholm, Sweden, 118 83
- Recruiting
- Södersjukhuset (South general hospital), Department of orthopedic surgery
-
Contact:
- Christian Inngul, M.D.
- Phone Number: 0046708355969
- Email: christian.inngul@sodersjukhuset.se
-
Principal Investigator:
- Christian Inngul, M.D.
-
Sub-Investigator:
- Anders Enocson, M.D. Ph.D.
-
Sub-Investigator:
- Richard Blomfeldt, M.D. Ph.D.
-
Sub-Investigator:
- Sari Ponzer, M.D. Prof
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- displaced fracture of the femoral neck
- independent living
- independent ambulation (with or without walking aids)
Exclusion Criteria:
- pathological fracture
- severe dementia (defined as ≤3 in short portable mental questionnaire) preoperatively
- preexisting ipsilateral hip disease
- neurological disease (e.g. M. Parkinson)
- psychiatric disease which makes understanding or following instructions impossible
- history of drug and alcohol abuse
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: uncemented hemiarthroplasty
Patients aged 80 or older with displaced femoral neck fracture treated with an uncemented hemiarthroplasty
|
Patients aged 80 years and older are randomized to uncemented hemiarthroplasty.
Fixation of the tapered, proximally hydroxyapatite coated, titanium stem to the host bone by "press-fit"-technique.
The acetabulum is not replaced.
The prosthesis articulates with the patients acetabulum with an unipolar, femoral head made of ChromCobalt steel.
Other Names:
|
Experimental: reverse hybrid total hip arthroplasty
Patients aged between 65 and 79 years treated with an reverse hybrid arthroplasty.
|
Patients aged 65 to 79 years operated with an uncemented femoral component combined with cemented acetabular cup.
The femoral stem is fixed to the host bone by press-fit technique.
We use a tapered, proximally hydroxyapatite coated, titanium stem.
The acetabular cup is fixed to the host bone with bone cement.
We use an all-polyethylene design.
Bone cement consists of PolyMetylMetAcrylat.
Other Names:
|
Active Comparator: cemented hemiarthroplasty
Patients aged 80 or older with displaced femoral neck fracture treated with an cemented hemiarthroplasty
|
Patients aged 80 years and older operated with an cemented hemiarthroplasty.
Fixation of the wedge-shaped, polished ChromCobalt steel femoral stem to host bone by use of PolyMetylMetAcrylat bone cement.
The acetabulum is not replaced.
The prosthesis articulates with the patients acetabulum with an unipolar, femoral head made of ChromCobalt steel.
Other Names:
|
Active Comparator: cemented total hip arthroplasty
Patients aged between 65 and 79 years treated with an cemented total hip arthroplasty.
|
Patients aged 65 to 79 years operated with a cemented femoral stem combined with a cemented acetabular cup.
Femoral and acetabular component are fixed to the host bone by use of bone cement.
The femoral stem is a polished, wedge-shaped design made of ChromCobalt steel.
The acetabular cup is fixed to the host bone with bone cement.The acetabular cup an all-polyethylene design.
Bone cement consists of PolyMetAcrylat.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Harris Hip Score
Time Frame: 12 month
|
Our primary outcome variable is the Harris Hip Score at 12 month follow up. Harris Hip Score is an investigator reported tool evaluating hip function in four dimensions: Pain, function, absence of deformity and range of motion |
12 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Health related quality of life
Time Frame: 12 month
|
We use the patient reported instrument EQ-5D.
A questionnaire consisting of 5 questions to evaluate health related quality of life.
|
12 month
|
Radiological follow up
Time Frame: 12 month
|
Evaluation of radiological outcome on standard hip radiographies with focus on bony ingrowth, signs of loosening and subsidence
|
12 month
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
General and surgical complications
Time Frame: from operation until 12 month postoperatively
|
general complications such as cardio-pulmonary events, pressure ulcer, pneumonia, deep vein thrombosis (DVT). surgical complications such as infections, reoperations due to all causes, dislocations |
from operation until 12 month postoperatively
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Sari Ponzer, M.D. Prof, Department of orthopedic surgery, South general hospital, Sjukhusbacken 10, 118 83 Stockholm, Sweden
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Wounds and Injuries
- Leg Injuries
- Femoral Fractures
- Hip Injuries
- Hip Fractures
- Fractures, Bone
- Femoral Neck Fractures
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Enzyme Inhibitors
- Gastrointestinal Agents
- Cytochrome P-450 Enzyme Inhibitors
- Anti-Ulcer Agents
- Histamine Antagonists
- Histamine Agents
- Cytochrome P-450 CYP1A2 Inhibitors
- Histamine H2 Antagonists
- Cimetidine
Other Study ID Numbers
- 2009/1188-31/1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Femoral Neck Fractures
-
Sundsvall HospitalCompletedFemoral Neck FractureSweden
-
Hospices Civils de LyonCompleted
-
RenJi HospitalRecruiting
-
Sorlandet Hospital HFCompleted
-
Hartford HospitalZimmer BiometCompletedFemoral Neck FractureUnited States
-
First Hospitals affiliated to the China PLA General...Unknown
-
Danderyd HospitalCompletedFemoral Neck FractureSweden
-
Istanbul UniversityCompletedFemoral Neck Fractures | Femoral Neck ShorteningTurkey
-
Hebei Medical University Third HospitalUnknown
-
University Hospital, AngersCompletedFemoral Neck FractureFrance
Clinical Trials on uncemented hemiarthroplasty
-
Peterborough and Stamford Hospitals NHS Foundation...Completed
-
Ullevaal University HospitalUnknownHemiarthroplasty | Femoral Neck Fractures | Bone Density | Acetabular WearNorway
-
Ullevaal University HospitalAsker & Baerum HospitalUnknown
-
Northern Orthopaedic Division, DenmarkWithdrawnFemoral Neck FracturesDenmark
-
Sykehuset Innlandet HFRikshospitalet University Hospital; Sykehuset Buskerud HFCompleted
-
Carlos AlvarezCompletedA02.835.232.087.090.400.400Spain
-
Sorlandet Hospital HFCompleted
-
Sorlandet Hospital HFCompletedHemiarthroplasty | Femoral Neck Fractures | Heterotopic OssificationNorway
-
Sahlgrenska University Hospital, SwedenZimmer BiometCompletedArthroplasty Complications
-
Danderyd HospitalZimmer BiometActive, not recruitingHip FracturesSweden